Insights from Structural Analysis of cFMS/Inhibitor Complexes: Common Interactions Via Three Structurally Dissimilar Scaffolds

Author(s): Renee L. DesJarlais.

Journal Name: Current Topics in Medicinal Chemistry

Volume 12 , Issue 11 , 2012

Become EABM
Become Reviewer


A small-molecule drug discovery effort can benefit from having several chemical series. Where multiple series are not available, it is often the goal of a project to find novel scaffolds. Structural studies of ligand/protein complexes provide important information on the interactions driving binding. By generalizing these, it is possible to find molecules lacking in similarity in their connectivity yet retaining the ability to interact with the same target protein. Our studies on inhibitors of the cFMS tyrosine kinase provide a dramatic example of three different chemical series that make the same key interactions with the target protein. Collectively, these structural data provide a striking example of the pharmacophore hypothesis at work. In addition, they should prompt one to employ a broad approach when attempting scaffold hopping or any search for a novel series. It is clear that molecules that bind with similar interactions to a target need not possess 2-dimensional molecular similarity.

Keywords: Structure-based drug discovery, cFMS, kinase inhibitor, ligand design, pharmacophore, drug discovery, scaffolds, on-target potency, generic binding assay, ATP-induced autophosphorylation assay, crystallography

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [1271 - 1281]
Pages: 11
DOI: 10.2174/156802612800672835
Price: $58

Article Metrics

PDF: 12